Anthony J. Swerdlow

Research interests

Publications

• Identification of nine new susceptibility loci for endometrial cancer

  Nature Communications · 2018 · 10.1038/s41467-018-05427-7

• Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women

  JAMA Oncology · 2018 · 10.1001/jamaoncol.2018.1771

• Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors

  Nature Genetics · 2017 · 10.1038/ng.3823

• Family history and risk of breast cancer: an analysis accounting for family structure

  Breast Cancer Research and Treatment · 2017 · 10.1007/s10549-017-4325-2

• Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.66.8178

• Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

  PLoS Medicine · 2016 · 10.1371/journal.pmed.1002105

• RAD51B in Familial Breast Cancer

  PLoS ONE · 2016 · https://doi.org/10.1371/journal.pone.0153788

• Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

  JNCI Journal of the National Cancer Institute · 2015 · https://doi.org/10.1093/jnci/djv036

• Genome-wide association studies identify four ER negative–specific breast cancer risk loci

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2561

• Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

  Nature Genetics · 2013 · https://doi.org/10.1038/ng.2566

• ICNIRP Guidelines for limiting exposure to time-varying electric and magnetic fields (1 Hz to 100 kHz).

  HAL (Le Centre pour la Communication Scientifique Directe) · 2010

• Genome-wide association study identifies five susceptibility loci for glioma

  Nature Genetics · 2009 · 10.1038/ng.407

• Mortality in Women with Turner Syndrome in Great Britain: A National Cohort Study

  The Journal of Clinical Endocrinology & Metabolism · 2008 · 10.1210/jc.2008-1049

• Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

  JNCI Journal of the National Cancer Institute · 2007 · 10.1093/jnci/djk029

• Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial

  Blood · 2007 · 10.1182/blood-2006-12-063008

• Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study

  JNCI Journal of the National Cancer Institute · 2005 · 10.1093/jnci/dji240

• Epidemiology of Health Effects of Radiofrequency Exposure

  Environmental Health Perspectives · 2004 · 10.1289/ehp.7306

• Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

  Diabetologia · 2003 · 10.1007/s00125-003-1116-6

• Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study

  The Lancet · 2002 · 10.1016/s0140-6736(02)09519-3

• Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells

  The Lancet · 2002 · 10.1016/s0140-6736(02)09672-1

• Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment

  Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.3.498

• The British Diabetic Association Cohort Study, II: cause‐specific mortality in patients with insulin‐treated diabetes mellitus

  Diabetic Medicine · 1999 · 10.1046/j.1464-5491.1999.00076.x

• The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus

  Diabetic Medicine · 1999 · 10.1046/j.1464-5491.1999.00075.x

• Trends in cancer incidence and mortality in Scotland: description and possible explanations

  British Journal of Cancer · 1998 · 10.1038/bjc.1998.424

• Benign melanocytic naevi as a risk factor for malignant melanoma.

  BMJ · 1986 · 10.1136/bmj.292.6535.1555

Current projects

No projects listed.